A Randomized, Phase II Study with Biomarker Analysis of Panobinostat with or without Rituximab in Relapsed Diffuse Large B Cell Lymphoma

被引：0
|
作者：
Assouline, Sarit [1 ]
Crump, Michael [2 ]
Nielsen, Torsten Holm [1 ]
Alcaide, Miguel [3 ]
Macdonald, David [4 ]
Tosikyan, Axel [5 ]
Haliotis, Tina [1 ]
Greenwood, Celia [1 ]
Oros, Kathleen Klein [1 ]
Morin, Ryan [3 ]
Johnson, Nathalie [6 ]
Mann, Koren Kathleen [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada
[4] QEII Hlth Sci Ctr, Halifax, NS, Canada
[5] Hop Sacre Coeur Montreal, Montreal, PQ, Canada
[6] McGill Univ, Jewish Gen Hosp, Hematol, Montreal, PQ H3T 1E2, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma
    Niitsu, Nozomi
    Kohri, Mika
    Hagiwara, Yuki
    Tanae, Ken
    Takahashi, Naoki
    Bessho, Masami
    Okamoto, Masataka
    HEMATOLOGICAL ONCOLOGY, 2010, 28 (02) : 68 - 74
  • [22] Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    Kim, Won Seog
    Kim, Seok Jin
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Won-Sik
    Oh, Sung Yong
    Park, Yong
    Kim, Sung-Yong
    Lee, Mark Hong
    Lee, Ho Sup
    Do, Young Rok
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1437 - 1443
  • [23] Pilot Study of Lenalidomide-Rituximab Combination in Relapsed/Refractory Diffuse Large B Cell Lymphoma
    Ivanov, Vadim
    Coso, Diane
    Aurran, Therese
    Schiano, Jean Marc
    Stoppa, Anne-Marie
    Rey, Jerome
    Broussais, Florence
    Blaise, Didier
    Bouabdallah, Reda
    BLOOD, 2012, 120 (21)
  • [24] Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
    Jeffrey L. Vacirca
    Peter. I. Acs
    Imad A. Tabbara
    Peter. J. Rosen
    Peter Lee
    Eric Lynam
    Annals of Hematology, 2014, 93 : 403 - 409
  • [25] Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patients
    Yamasaki, Satoshi
    Kada, Akiko
    Choi, Ilseung
    Iida, Hiroatsu
    Sekiguchi, Naohiro
    Harada, Naoko
    Sawamura, Morio
    Shimomura, Takeshi
    Komeno, Takuya
    Yano, Takahiro
    Yoshida, Isao
    Yoshida, Shinichiro
    Sunami, Kazutaka
    Hishita, Terutoshi
    Takatsuki, Hiroshi
    Ohshima, Koichi
    Takeshita, Morishige
    Saito, Akiko M.
    Iwasaki, Hiromi
    Nagai, Hirokazu
    EJHAEM, 2020, 1 (02): : 507 - 516
  • [26] Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma
    Duehrsen, Ulrich
    Tometten, Mareike
    Kroschinsky, Frank
    Ganser, Arnold
    Ibach, Stefan
    Bertram, Stefanie
    Huettmann, Andreas
    BLOOD CANCER JOURNAL, 2021, 11 (05)
  • [27] Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma
    Ulrich Dührsen
    Mareike Tometten
    Frank Kroschinsky
    Arnold Ganser
    Stefan Ibach
    Stefanie Bertram
    Andreas Hüttmann
    Blood Cancer Journal, 11
  • [28] Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
    Vacirca, Jeffrey L.
    Acs, Peter I.
    Tabbara, Imad A.
    Rosen, Peter J.
    Lee, Peter
    Lynam, Eric
    ANNALS OF HEMATOLOGY, 2014, 93 (03) : 403 - 409
  • [29] Use of gemcitabine, cisplatin and methylprednisolone with or without rituximab in relapsed and refractory patients with diffuse large B-cell lymphoma
    Sirohi, B
    Cunningham, D
    Norman, A
    Trumper, M
    Prior, Y
    Last, K
    Chong, G
    Horwich, A
    Wotherspoon, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S240 - S240
  • [30] Phase II study of the CPT-11, mitoxantrone and dexamethasone regimen in combination with rituximab in elderly patients with relapsed diffuse large B-cell lymphoma
    Niitsu, Nozomi
    Kohuri, Mika
    Higashihara, Masaaki
    Bessho, Masami
    CANCER SCIENCE, 2006, 97 (09) : 933 - 937
12345